Interventional Radiology · 2019-04-05 · Diagmed IR4 Interventional Radiology Introducing the...

InterventionalRadiology

M A K I N G A D I F F E R E N C E T O H E A L T H

About Us

Diagmed Healthcare Ltd is an independent, family owned distributor of numerous Gold Standard devices. By continuously striving to improve our service and offering for over 35 years we have remained relevant and competitive in an increasingly globalised market place. Our values of honesty, open communication, integrity and passion for our products and services allow us to meet and exceed customer expectations and ultimatelybenefit their patients.

At Diagmed Healthcare Ltd we recognise the ever-changing needs, demands and choice in Interventional Radiology and welcome you to our innovative self-expanding stent range.

Contents

Key Features of the Stent 4

Delivery System 5

Biliary Stents 6

Duodenal Stents 10

Colorectal Stents 12

Oesophageal Stents 13

4Diagmed IR

Interventional Radiology

Introducing the updated range of the Hanarostent® conformable self-expanding stents, specifically designed to meet the demands of Interventional Radiologists.

Key Features of Stent:

• Highly visible fluoroscopic markers to aid accurate first time placement

• Hook and Cross knitted single and twin-layered nitinol mesh allow the stent to conform to the lumen rather than the lumen conforming to the stent

• Uncovered, partially covered and fully covered options• Fully covered stents have CE license for removability• Unique features to reduce the risk of stent migration• Stent options for effective management of gastric reflux

Diagmed IR 5

Dedicated contrast port for intraprocedural use

Safety lock on handle to prevent accidental stent deployment

Fully resheathable with accurate point-of-no-return marker

KEY FEATURES OF DELIVERY SYSTEM

Soft and atraumatic distal olive tip

Smooth and accurate deployment mechanism

Optimal length and calibre for Interventional Radiology

“Optimal length and calibre for Interventional

Radiology”

SHS - UNCOVERED STENT

Indication: For application in palliative treatment of biliary stricture, typically caused by malignant tumours

6Diagmed IR 7Diagmed IR

Biliary Stents

BNA - UNCOVERED STENT

Indication: Indicated for the palliation of malignant strictures in the common bile duct

Ordering Information

Product Code

Stent (mm) Delivery Device Box Size Usable

LengthTotal

Length Diameters Length (cm)

Diameter (mm/Fr)

BNA10060-H060 46 60 13.5-10-13.5 60 2.66 / 8 1

BNA10080-H060 66 80 13.5-10-13.5 60 2.66 / 8 1


Product Code


LengthTotal


Diameter (mm/Fr)

SHS-10-060-060 46 60 13.5-10-13.5 60 2.33 / 7 1

SHS-10-080-060 66 80 13.5-10-13.5 60 2.33 / 7 1

SHS-10-100-060 86 100 13.5-10-13.5 60 2.33 / 7 1

FEATURE BENEFIT

Hybrid wire weave structure Lower returning force allow stent to better conform to the shape of the lumen

Thicker nitinol wire than other leading stents

Quicker expansion and more balanced radial force to maintain luminal patency in tortuous

anatomy

Rounder edges Minimise the risk of mucosal trauma

9 radio-opaque gold markings Excellent visualisation under fluoroscopic guidance

BNHS - UNCOVERED STENT

Indication: The non-covered BenefitTM Biliary Stent is used for application in palliative treatment of bile duct stricture caused by malignant tumours

8Diagmed IR Diagmed IR


Product Code


LengthTotal


Diameter (mm/Fr)

BNHS-08-100-060 86 100 8-8-8 60 1.98 / 5.9 1

BNHS-08-120-060 106 120 8-8-8 60 1.98 / 5.9 1

BNY - UNCOVERED STENT

Indication: For application in palliative treatment of biliary strictures and/or Klatskin-type malignant tumours


Product Code


LengthTotal


Diameter (mm/Fr)

BNY-10-060-060 46 60 13.5-10-13.5 60 2.33 / 7 1

BNY-10-080-060 66 80 13.5-10-13.5 60 2.33 / 7 1


Product Code


LengthTotal


Diameter (mm/Fr)

BCG-10-060-060 40 60 10-10-10 60 2.83 / 8.5 1

BCG-10-080-060 60 80 10-10-10 60 2.83 / 8.5 1

BCG-10-100-060 80 100 10-10-10 60 2.83 / 8.5 1

9

Indication: For the application in palliative treatment of biliary stricture and/or closure of perforations and post-surgical leaks and fistula by malignant or benign tumours

BCG - FULLY COVERED STENT

10Diagmed IR


Product Code


LengthTotal


Diameter (mm/Fr)

TLD-22-110-120 80 110 28-22-28 120 3.4 / 10.2 1

TLD-22-140-120 110 140 28-22-28 120 3.4 / 10.2 1


Product Code


LengthTotal


Diameter (mm/Fr)

DPDL-20-090-120 62 90 22-20-40 120 3.4 / 10.2 1

DPDL-20-110-120 82 110 22-20-40 120 3.4 / 10.2 1

DPDL-20-130-120 102 130 22-20-40 120 3.4 / 10.2 1

Diagmed IR 11

DNZL - UNCOVERED STENT

Indication: This uncovered dual-weave stent is indicated for application in palliative treatment of duodenal or pyloric strictures


Product Code


LengthTotal


Diameter (mm/Fr)

DNZL-20-080-120 50 80 26-20-26 120 3.4 / 10.2 1

DNZL-20-110-120 80 110 26-20-26 120 3.4 / 10.2 1

DNZL-20-140-120 110 140 26-20-26 120 3.4 / 10.2 1

TLD - PARTIALLY COVERED STENT

Indication: This partially covered dual-weave stent is indicated for application in palliative treatment of duodenal or pyloric strictures

FEATURE BENEFIT

Twin Layered nitinol with hook and cross weave structure

Provides strength, patency and conformability to the D1 duodenal bulb

Large 40mm proximal uncovered Kim’s Flare and uncovered distal flared end Minimises the risk of stent migration

Silicone membrane between the two mesh layers Reduces the risk of tumour ingrowth

16 radio-opaque markers on stent Excellent visibility under fluoroscopy to aid accurate positioning

DPDL - PARTIALLY COVERED STENT

Indication: This partially covered dual-weave stent is indicated for application in palliative treatment of duodenal or pyloric strictures

Duodenal Stents

CNZ - UNCOVERED STENT

Indication: This uncovered dual-weave stent is indicated for application in palliative treatment of stricture in the large bowel caused by malignant colonic obstruction


Product Code


LengthTotal


Diameter (mm/Fr)

CNZ-24-110-140 80 110 30-24-30 140 4 / 12 1

CNZ-24-140-140 110 140 30-24-20 140 4 / 12 1

Colorectal Stents

FEATURE BENEFIT

Twin Layered nitinol with hook and cross weave structure

Provides strength, patency and conformability to the colon

Flared stent ends Minimises the risk of stent migration

Dedicated IR delivery system with repositioning markers

Allows intraprocedural injection of contrast for accurate stent placement

12 radio-opaque markers on stent Excellent visibility under fluoroscopy to aid accurate positioning

TLC - PARTIALLY COVERED STENT

Indication: This partially covered dual-weave stent is indicated for application in palliative treatment of stricture in the large bowel caused by malignant colonic obstruction


Product Code


LengthTotal


Diameter (mm/Fr)

TLC-22-100-140 70 100 28-22-28 140 3.4 / 10.2 1

TLC-22-140-140 110 140 28-22-28 140 3.4 / 10.2 1

Oesophageal Stents

EPV - PARTIALLY COVERED STENT

Indication: Partially covered oesophageal stent with anti-reflux valve. Indicated for the treatment of malignant strictures in the distal oesophagus

12Diagmed IR Diagmed IR 13

14Diagmed IR


FEATURE BENEFIT

Partial silicone inner stent covering

Significantly reduces the risk of ingrowth and helps facilitate repositioning

S-valve in distal section of stent The closed-type S valve allows room for food passage whilst controlling gastric reflux

Dedicated 24fr delivery device with atraumatic distal olive tip

Allows for smooth radiological stent placement

12 radio-opaque markers on stent

Aids accurate stent positioning under fluoroscopy

Product Code


LengthTotal


Diameter (mm/Fr)

EPV22100-Z070 60 100 28-22-28 70 8 / 24 1

EPV22120-Z070 80 120 28-22-28 70 8 / 24 1

EPV22140-Z070 100 140 28-22-28 70 8 / 24 1

15Diagmed IR


Product Code


LengthTotal


Diameter (mm/Fr)

ECN180090-X070 60 90 24-18-24 70 6 / 18 1

ECN180110-X070 80 110 24-18-24 70 6 / 18 1

ECW - PARTIALLY COVERED STENT

Indication: Fully covered oesophageal stent with anti-reflux valve. Indicated for the treatment of malignant or benign strictures in the distal oesophagus. CE mark for benign indications - can be safely removed within 4 weeks of placement

ECN - FULLY COVERED STENT

Indication: For application in palliative treatment of a benign stricture in the oesophageal lumen and/or benign fistula in the Oesophagus. Has a CE mark for benign indications. Can be safely removed within 6 weeks of placement


Product Code


LengthTotal


Diameter (mm/Fr)

ECW22090-Z080 50 90 28-22-28 70 8 / 24 1

ECW22120-Z070 80 120 28-22-28 70 8 / 24 1

ECW22160-Z070 120 160 28-22-28 70 8 / 24 1

Lumley Close, Thirsk Industrial Park, Thirsk, North Yorkshire, England, YO7 3TD01845 526660 | [email protected] | diagmed.healthcare

Interventional Radiology · 2019-04-05 · Diagmed IR4 Interventional Radiology Introducing the...

Documents

Transcript of Interventional Radiology · 2019-04-05 · Diagmed IR4 Interventional Radiology Introducing the...